Compounds > 5-carboxamidotryptamine
Page last updated: 2024-10-21

5-carboxamidotryptamine and Neurodevelopmental Disorders

5-carboxamidotryptamine has been researched along with Neurodevelopmental Disorders in 1 studies

5-carboxamidotryptamine: agonist of 5-HT receptor; structure given in first source

Neurodevelopmental Disorders: These are a group of conditions with onset in the developmental period. The disorders typically manifest early in development, often before the child enters grade school, and are characterized by developmental deficits that produce impairments of personal, social, academic, or occupational functioning. (From DSM-5).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Modica, MN1
Lacivita, E1
Intagliata, S1
Salerno, L1
Romeo, G1
Pittalà, V1
Leopoldo, M1

Other Studies

1 other study available for 5-carboxamidotryptamine and Neurodevelopmental Disorders

ArticleYear
Structure-Activity Relationships and Therapeutic Potentials of 5-HT
    Journal of medicinal chemistry, 2018, 10-11, Volume: 61, Issue:19

    Topics: Animals; Antidepressive Agents; Central Nervous System Diseases; Humans; Ligands; Neurodevelopmental

2018